Low dose IL-15 induces snap arming of CD44low T lymphocytes in the absence of antigen

Cellular Immunology

Volumn 251, Issue 2, 2008, Pages 93-101

  Tamang, David L ^a   Alves, Bryce N ^a   Elliott, Viki ^a   Fraser, Stephanie A ^b   Redelman, Doug ^c   Hudig, Dorothy ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Cytotoxic T lymphocyte; Granzyme B; IL 15; IL 2

Indexed keywords

GRANZYME B; HERMES ANTIGEN; INTERLEUKIN 15;

ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS; ANTIGENS, CD44; CD8-POSITIVE T-LYMPHOCYTES; CELL GROWTH PROCESSES; CYTOTOXICITY TESTS, IMMUNOLOGIC; GRANZYMES; IMMUNOLOGIC MEMORY; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERFORIN; PHENOTYPE; SPLEEN;

MURINAE;

EID: 47249118331     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.04.007     Document Type: Article

References (45)

1. Bretscher P., and Cohn M. A theory of self-nonself discrimination. Science 169 (1970) 1042-1049
2. + T cell activation. Int. Immunol. 10 (1998) 619-630
3. Janas M.L., Groves P., Kienzle N., and Kelso A. IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation. J. Immunol. 175 (2005) 8003-8010
4. Shurin M.R., Tourkova I.L., Hackstein H., and Shurin G.V. Interleukin-15 and 21. In: Thomson A.W., and Lotze M.T. (Eds). The Cytokine Handbook (2003), Elsevier Science Ltd., London 431-463
5. Lin J.-X., and Leonard W.J. Interleukin-15 and 21. In: Thomson A.W., and Lotze M.T. (Eds). The Cytokine Handbook (2003), Elsevier Science Ltd., London 167-199
6. Waldmann T.A., Dubois S., and Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14 (2001) 105-110
7. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L.S., and Anderson D.M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14 (1995) 3654-3663
8. Anderson D.M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., Giri J., Copeland N.G., Gilbert D.J., and Jenkins N.A. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270 (1995) 29862-29869
9. Robb R.J., Munck A., and Smith K.A. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J. Exp. Med. 154 (1981) 1455-1474
10. Johnston J.A., Bacon C.M., Finbloom D.S., Rees R.C., Kaplan D., Shibuya K., Ortaldo J.R., Gupta S., Chen Y.Q., and Giri J.D. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92 (1995) 8705-8709
11. Johnston J.A., Kawamura M., Kirken R.A., Chen Y.Q., Blake T.B., Shibuya K., Ortaldo J.R., McVicar D.W., and O'Shea J.J. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370 (1994) 151-153
12. Witthuhn B.A., Silvennoinen O., Miura O., Lai K.S., Cwik C., Liu E.T., and Ihle J.N. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370 (1994) 153-157
13. Dubois S., Mariner J., Waldmann T.A., and Tagaya Y. IL-15R[alpha] Recycles and Presents IL-15 In trans to Neighboring Cells. Immunity 17 (2002) 537-547
14. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., and Caligiuri M.A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180 (1994) 1395-1403
15. Kuribayashi K., Gillis S., Kern D.E., and Henney C.S. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J. Immunol. 126 (1981) 2321-2327
16. Liu K., Catalfamo M., Li Y., Henkart P.A., and Weng N.P. IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc. Natl. Acad. Sci. USA 99 (2002) 6192-6197
17. Alves N.L., Hooibrink B., Arosa F.A., and van Lier R.A. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102 (2003) 2541-2546
18. Numbenjapon T., Serrano L.M., Chang W.C., Forman S.J., Jensen M.C., and Cooper L.J. Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells. Exp. Hematol. 35 (2007) 1083-1090
19. Leonhartsberger N., Ramoner R., Putz T., Gander H., Rahm A., Falkensammer C., Bartsch G., and Thurnher M. Antigen-independent immune responses after dendritic cell vaccination. Cancer Immunol. Immunother. 56 (2007) 897-903
20. Wherry E.J., Barber D.L., Kaech S.M., Blattman J.N., and Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 101 (2004) 16004-16009
21. Allan M.J., Callard R., Stark J., and Yates A. Comparing antigen-independent mechanisms of T cell regulation. J. Theor. Biol. 228 (2004) 81-95
22. Williams L.D., McMaster W.R., and Teh H.S. Antigen-independent activation of cytotoxic T cells by lymphokines. Immunology 64 (1988) 121-128
23. Lefrancois L., Klein J.R., Paetkau V., and Bevan M.J. Antigen-independent activation of memory cytotoxic T cells by interleukin 2. J. Immunol. 132 (1984) 1845-1850
24. Tamang D.L., Redelman D., Alves B.N., Vollger L., Bethley C., and Hudig D. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal. Cytokine 36 (2006) 148-159
25. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., and Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369 (1994) 31-37
26. Walsh C.M., Matloubian M., Liu C.C., Ueda R., Kurahara C.G., Christensen J.L., Huang M.T., Young J.D., Ahmed R., and Clark W.R. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91 (1994) 10854-10858
27. Pross H.F., and Maroun J.A. The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 68 (1984) 235-249
28. Overton W.R. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9 (1988) 619-626
29. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., Brasel K., Morrissey P.J., Stocking K., Schuh J.C., Joyce S., and Peschon J.J. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191 (2000) 771-780
30. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., and Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9 (1998) 669-676
31. Hasan M.S., Kallas E.G., Thomas E.K., Looney J., Campbell M., and Evans T.G. Effects of interleukin-15 on in vitro human T cell proliferation and activation. J. Interferon Cytokine Res. 20 (2000) 119-123
32. Weng N.P., Liu K., Catalfamo M., Li Y., and Henkart P.A. IL-15 is a growth factor and an activator of CD8 memory T cells. Ann. NY Acad. Sci. 975 (2002) 46-56
33. Fleming T.J., Fleming M.L., and Malek T.R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151 (1993) 2399-2408
34. Han G.W., Iwatsuki K., Inoue M., Matsui T., Nishibu A., Akiba H., and Kaneko F. Interleukin-15 is not a constitutive cytokine in the epidermis, but is inducible in culture or inflammatory conditions. Acta Derm. Venereol. 79 (1999) 37-40
35. Rappl G., Kapsokefalou A., Heuser C., Rossler M., Ugurel S., Tilgen W., Reinhold U., and Abken H. Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha. J. Invest. Dermatol. 116 (2001) 102-109
36. Cercek M., Matsumoto M., Li H., Chyu K.Y., Peter A., Shah P.K., and Dimayuga P.C. Autocrine role of vascular IL-15 in intimal thickening. Biochem. Biophys. Res. Commun. 339 (2006) 618-623
37. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., and Surh C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98 (2001) 8732-8737
38. Tagaya Y., Burton J.D., Miyamoto Y., and Waldmann T.A. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 15 (1996) 4928-4939
39. Lantz O., and Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J. Exp. Med. 180 (1994) 1097-1106
40. MacDonald H.R. NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function. J. Exp. Med. 182 (1995) 633-638
41. Kanegane H., and Tosato G. Activation of naive and memory T cells by interleukin-15. Blood 88 (1996) 230-235
42. Cho J.H., Boyman O., Kim H.O., Hahm B., Rubinstein M.P., Ramsey C., Kim D.M., Surh C.D., and Sprent J. An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J. Exp. Med. 204 (2007) 1787-1801
43. Berard M., Brandt K., Bulfone-Paus S., and Tough D.F. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J. Immunol. 170 (2003) 5018-5026
44. Klebanoff C.A., Finkelstein S.E., Surman D.R., Lichtman M.K., Gattinoni L., Theoret M.R., Grewal N., Spiess P.J., Antony P.A., Palmer D.C., Tagaya Y., Rosenberg S.A., Waldmann T.A., and Restifo N.P. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc. Natl. Acad. Sci. USA 101 (2004) 1969-1974
45. Kutzler M.A., Robinson T.M., Chattergoon M.A., Choo D.K., Choo A.Y., Choe P.Y., Ramanathan M.P., Parkinson R., Kudchodkar S., Tamura Y., Sidhu M., Roopchand V., Kim J.J., Pavlakis G.N., Felber B.K., Waldmann T.A., Boyer J.D., and Weiner D.B. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J. Immunol. 175 (2005) 112-123